Immunotherapy company Harpoon Therapeutics has won a $70 million Series C funding round, with which it plans to expand its TriTAC and ProTriTAC platforms, the latter of which was unveiled just days…
![](https://redherring.wpenginepowered.com/wp-content/uploads/2018/11/Screen-Shot-2018-11-12-at-12.33.54-PM-150x150.png)
![](https://redherring.wpenginepowered.com/wp-content/uploads/2018/11/Screen-Shot-2018-11-12-at-12.33.54-PM.png)
THE BUSINESS OF TECHNOLOGY
Immunotherapy company Harpoon Therapeutics has won a $70 million Series C funding round, with which it plans to expand its TriTAC and ProTriTAC platforms, the latter of which was unveiled just days…
A brewfest at a baseball stadium is not the most obvious place to discover a vibrant tech ecosystem. But at the OKBio BrewFest earlier this month, at Oklahoma City’s Chickasaw Bricktown Ballpark,…